Improving Management of Patients at High Risk for Osteoporotic Fractures
This study has been completed.
Information provided by:
First received: August 29, 2005
Last updated: October 25, 2009
Last verified: October 2009
The purpose of this study is to assess the impact of disease management interventions on percent receiving a bone densitometry test and percent appropriately prescribed a medication for osteoporosis.
|Study Design:||Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Open Label
|Official Title:||Improving Management of Patients at High Risk for Osteoporotic Fractures|
Resource links provided by NLM:
Further study details as provided by Merck:
Primary Outcome Measures:
- A composite measure of bone mineral density (BMD) testing and/or osteoporosis medications prescriptions.
Secondary Outcome Measures:
- BMD testing, osteoporosis medication prescriptions, fracture
|Study Start Date:||September 2004|
|Primary Completion Date:||June 2005 (Final data collection date for primary outcome measure)|
Contacts and Locations